PET scan to study lung scarring in people with ILD
Treatments studied
Part of Immune system & allergy, Injuries & trauma, Lungs & breathing clinical trials.
This early-phase study uses a special PET scan to look at a substance linked to lung scarring (fibrosis) in people with ILD (interstitial lung disease). The goal is to see whether the scan can help measure lung disease activity and support future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older) when you receive the tracer for the PET scan.
- Your ILD has been confirmed on a CT scan (a scan that takes detailed pictures of your lungs).
- In the 3 months around enrolling, you either start a new ILD medication or plan to have a lung tissue biopsy or lung surgery.
- You can sign a consent form (written permission) and understand the study steps.
- You are not pregnant or breastfeeding.
- You do not currently have an active lung infection.
- You can follow all study visit instructions and complete the required study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This study uses a special PET scan (68Ga-1A12) to look for scarring (fibrosis) in your body. The scan may help doctors see where fibrosis is happening, which could guide your treatment.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.